Whitehawk Therapeutics Inc Statistics Share Statistics Whitehawk Therapeutics Inc has 47.11M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 47.11M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 4,859 FTD / Avg. Volume 4.23%
Short Selling Information The latest short interest is 381.94K, so 0.81% of the outstanding
shares have been sold short.
Short Interest 381.94K Short % of Shares Out 0.81% Short % of Float 1.08% Short Ratio (days to cover) 3.1
Valuation Ratios The PE ratio is -1.34 and the forward
PE ratio is -0.9.
Whitehawk Therapeutics Inc's PEG ratio is
0.41.
PE Ratio -1.34 Forward PE -0.9 PS Ratio 3.29 Forward PS 2.2 PB Ratio 1.63 P/FCF Ratio -1.4 PEG Ratio 0.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Whitehawk Therapeutics Inc.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.59 Quick Ratio 3.28 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -438.04
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $649.58K Profits Per Employee $-1.59M Employee Count 40 Asset Turnover 0.37 Inventory Turnover 10.18
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 22.46% in the
last 52 weeks. The beta is 0.64, so Whitehawk Therapeutics Inc's
price volatility has been higher than the market average.
Beta 0.64 52-Week Price Change 22.46% 50-Day Moving Average 1.88 200-Day Moving Average 2.17 Relative Strength Index (RSI) 43.03 Average Volume (20 Days) 114,991
Income Statement In the last 12 months, Whitehawk Therapeutics Inc had revenue of 25.98M
and earned -63.69M
in profits. Earnings per share was -2.36.
Revenue 25.98M Gross Profit -28.07M Operating Income -67.46M Net Income -63.69M EBITDA -64.63M EBIT -64.82M Earnings Per Share (EPS) -2.36
Full Income Statement Balance Sheet The company has 28.67M in cash and 833K in
debt, giving a net cash position of 27.84M.
Cash & Cash Equivalents 28.67M Total Debt 833K Net Cash 27.84M Retained Earnings -332.65M Total Assets 234M Working Capital 220.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.55M
and capital expenditures -1.65M, giving a free cash flow of -61.2M.
Operating Cash Flow -59.55M Capital Expenditures -1.65M Free Cash Flow -61.2M FCF Per Share -2.26
Full Cash Flow Statement Margins Gross margin is -108.04%, with operating and profit margins of -259.62% and -245.13%.
Gross Margin -108.04% Operating Margin -259.62% Pretax Margin -245.13% Profit Margin -245.13% EBITDA Margin -248.73% EBIT Margin -259.62% FCF Margin -235.55%
Dividends & Yields WHWK does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for WHWK.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 27, 2021. It was a
forward
split with a ratio of 15:1.
Last Split Date Aug 27, 2021 Split Type forward Split Ratio 15:1
Scores Altman Z-Score 2.88 Piotroski F-Score 5
